21 – 30 of 111
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Applications of Artificial Intelligence in PSMA PET/CT for Prostate Cancer Imaging
(2023) In Seminars in Nuclear Medicine
- Contribution to journal › Article
-
Mark
Conservative Management First Strategy in Aortic Vascular Graft and Endograft Infections
- Contribution to journal › Article
-
Mark
Re : Laura S. Mertens, Richard P. Meijer, J. Alfred Witjes. Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.017
- Contribution to journal › Letter
-
Mark
Metabolic parameters of [18F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer
- Contribution to journal › Article
-
Mark
[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging.
- Contribution to journal › Article
-
Mark
PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h
- Contribution to journal › Article
-
Mark
AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT
- Contribution to journal › Article
-
Mark
Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence : The PET index
- Contribution to journal › Article
-
Mark
[18F]PSMA-1007 renal uptake parameters: Reproducibility and relationship to estimated glomerular filtration rate
- Contribution to journal › Article
- 2022
-
Mark
Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer
- Contribution to journal › Article
